ICD-10-CM Billable Code

F18.921

Inhalant use, unspecified with intoxication with delirium

Clinical Classification Guidelines

Medical Intelligence & Overview

Inhalant use with intoxication and delirium is a medical condition characterized by the misuse of inhalant substances that leads to a state of intoxication accompanied by mental confusion or altered consciousness. This condition can result from inhaling fumes from various household or industrial products, which can have serious health effects. Recognizing the signs and understanding the nature of this condition is important for appropriate intervention and treatment.

Causes & Symptoms

Clinical Causes: Inhalation of volatile substances found in products such as glue, paint, aerosols, gasoline, or cleaning agents Repeated or chronic use of inhalants to achieve a psychoactive effect Lack of awareness about the health risks associated with inhalant abuse Psychosocial factors such as peer pressure, stress, or mental health issues Accessibility to inhalant products without restrictions

Key Symptoms: Euphoria or a feeling of being high Slurred speech Lack of coordination or staggering gait Dizziness or lightheadedness Nausea and vomiting Confusion and disorientation Altered mental state or delirium Visual or auditory hallucinations Mood swings or agitation Increased heart rate or irregular heartbeat Loss of consciousness in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment by a healthcare professional. It includes reviewing the patient's history of inhalant use, observing physical and mental symptoms, and ruling out other causes of altered mental states. Laboratory tests such as blood or urine screening may be used to identify specific inhalants or substances involved. Medical professionals may also conduct neurological evaluations to assess the extent of neurological impairment.

Treatment Protocols: Treatment for inhalant intoxication with delirium typically involves supportive medical care and safeguarding the patient's safety. Approaches may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F18.921 a billable ICD-10 code?
Yes, F18.921 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F18.921?
Clinical documentation must specify the nature of Inhalant use, unspecified with intoxication with delirium and any associated comorbidities for accurate reporting.

Cite this Clinical Reference